| J Desiree Pineda, MD | |
|
2440 M St Nw, 712, Washington, DC 20037-1404 | |
| (202) 828-0935 | |
| (202) 828-0938 |
| Full Name | J Desiree Pineda |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 2440 M St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720150279 | NPI | - | NPPES |
| 02341810 | Medicaid | DC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 19288 (District Of Columbia) | Primary |
| Entity Name | J Desiree Pineda Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568535318 PECOS PAC ID: 7719083625 Enrollment ID: O20070509000071 |
News Archive
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Over the last decade, a rising health consciousness has led 30,000 fitness clubs to open across the country, serving more than 58 million members annually. Valued at well over 20 billion dollars, the exercise industry is always on the lookout for the next big idea to continue its rapid growth. With that in mind, on Tuesday, October 20 at 10/9c, Spike debuts "Sweat Inc.," an unscripted competition series hosted and judged by acclaimed health and wellness expert, Jillian Michaels.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| J Desiree Pineda, MD 2440 M St Nw, 712, Washington, DC 20037-1404 Ph: (202) 828-0935 | J Desiree Pineda, MD 2440 M St Nw, 712, Washington, DC 20037-1404 Ph: (202) 828-0935 |
News Archive
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Over the last decade, a rising health consciousness has led 30,000 fitness clubs to open across the country, serving more than 58 million members annually. Valued at well over 20 billion dollars, the exercise industry is always on the lookout for the next big idea to continue its rapid growth. With that in mind, on Tuesday, October 20 at 10/9c, Spike debuts "Sweat Inc.," an unscripted competition series hosted and judged by acclaimed health and wellness expert, Jillian Michaels.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
Dr. Adefolaju Oketokun, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |